Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897910 · ClinicalTrials.gov registry record
Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma
A clinical trial, sponsored by Barbara Ann Karmanos Cancer Institute.
- Terminated
- Registry status
- 6
- Enrollment target
NCT00897910 is a clinical trial that was terminated before completion, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 6 participants.
The verdict
NCT00897910 was terminated before completion, sponsored by Barbara Ann Karmanos Cancer Institute.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about T cells and plan better treatment for multiple myeloma. PURPOSE: This research study is looking at T cells in blood and bone marrow samples from patients with multiple myeloma.
Interventions
- OTHER laboratory biomarker analysis
- OTHER flow cytometry
- OTHER immunoenzyme technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00897910
The ClinicalTrials.gov registry entry for NCT00897910 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00897910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00897910 about?
NCT00897910 is a clinical study titled "Studying T Cells in Blood and Bone Marrow Samples From Patients With Multiple Myeloma". RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about T cells and plan better treatment for multiple myeloma. PURPOSE: This research study is looking at T cells in blood and bone marrow samples from patients with multiple ...
What is the current status of trial NCT00897910?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2008-04. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00897910?
The interventions under investigation include: laboratory biomarker analysis (OTHER), flow cytometry (OTHER), immunoenzyme technique (OTHER).
Who is sponsoring clinical trial NCT00897910?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.